发明名称 |
Glycosaminoglycans |
摘要 |
Heparan sulphate HS/BMP2 is disclosed, together with the use of HS/BMP2 in the repair and regeneration of bone tissue. |
申请公布号 |
US9498494(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201213603569 |
申请日期 |
2012.09.05 |
申请人 |
AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
发明人 |
Cool Simon McKenzie;Nurcombe Victor;Dombrowski Christian |
分类号 |
A61K31/727;A61K38/18;A61L27/54;C08B37/00;C08B37/10;A61L27/20;A61K9/00 |
主分类号 |
A61K31/727 |
代理机构 |
Swanson & Bratschun, L.L.C. |
代理人 |
Swanson & Bratschun, L.L.C. |
主权项 |
1. A composition comprising a solid or solidified scaffold coated or impregnated with a therapeutically effective amount of an isolated or substantially purified heparan sulphate composition comprising a heparan sulphate component, wherein the heparan sulphate component is at least 97% isolated or substantially purified heparan sulphate HS/BMP2, wherein following digestion with heparin lyases I, II and III and then subjecting the resulting disaccharide fragments to capillary electrophoresis analysis the heparan sulphate HS/BMP2 has a disaccharide composition comprising:Normalised weightDisaccharidepercentageΔHexUA,2SGlcNS,6S14.8 ± 3.0ΔHexUA,2S-GlcNS 4.9 ± 2.0ΔHexUA-GlcNS,6S11.1 ± 3.0ΔHexUA,2SGlcNAc,6S 4.8 ± 2.0ΔHexUA-GlcNS22.2 ± 3.0ΔHexUA,2S-GlcNAc 1.1 ± 0.5ΔHexUA-GlcNAc,6S10.1 ± 3.0ΔHexUA-GlcNAc31.1 ± 3.0. |
地址 |
Singapore SG |